Skip to content
AnalystLens

CVS HEALTH Corp 8-K Report, Corporate Update (Dec 10, 2024)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed December 10, 2024
Period End
December 10, 2024
Security
CVS
In the record · 2016–202610-K1110-Q328-K181

CVS filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 181 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Nov ’18Nov ’18
  2. Leadership change8-K · Sep ’22Sep ’22
  3. Leadership change8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed December 10, 2024. Cited figures are marked; the original filing is the authoritative source.

CVS Health Corporation has announced the successful issuance and sale of a significant amount of junior subordinated notes, totaling $3.0 billiona.

This includes $2.25 billionb in Series A Junior Subordinated Notes due 2055 with a 7.000% fixed-to-fixed rate, and $750 million in Series B Junior Subordinated Notes due 2054 with a 6.750% fixed-to-fixed rate. These notes were offered under the company's existing Form S-3ASR registration statement filed in May 2023. This debt issuance represents a strategic move by CVS Health to bolster its capital structure.

The junior subordinated nature of these notes suggests they are intended to enhance the company's financial flexibility, potentially for future investments, acquisitions, or to manage existing debt obligations. Investors should note the specific interest rates and maturity dates, as well as the subordinated status which implies a higher risk profile compared to senior debt but offers a corresponding yield.

Key Highlights

  1. CVS Health issued $2.25 billion of 7.000% Series A Junior Subordinated Notes due 2055.
  2. CVS Health issued $750 million of 6.750% Series B Junior Subordinated Notes due 2054.
  3. Total aggregate principal amount of notes issued is $3.0 billion.
  4. The notes are junior subordinated, indicating a specific position in the capital structure.
  5. The issuance was conducted under the company's Form S-3ASR registration statement.
  6. The notes are governed by a Base Indenture and specific Supplemental Indentures.
  7. The company may issue additional subordinated debt securities under the Base Indenture.

Frequently Asked Questions

  1. What is the total amount of debt CVS Health raised in this filing?

    CVS Health raised a total of $3.0 billion through the issuance of its Series A and Series B Junior Subordinated Notes.

  2. What are the interest rates and maturity dates for these new notes?

    The Series A Junior Subordinated Notes have a fixed-to-fixed rate of 7.000% and mature in 2055. The Series B Junior Subordinated Notes have a fixed-to-fixed rate of 6.750% and mature in 2054.

  3. What does 'junior subordinated' mean for these notes?

    Junior subordinated notes are subordinate to other senior debt obligations of the company. In the event of bankruptcy or liquidation, holders of junior subordinated notes would be paid after holders of senior debt, making them a higher risk but typically offering a higher yield.

  4. Why would CVS Health issue subordinated debt?

    Issuing subordinated debt can enhance a company's financial flexibility, potentially improve credit ratings (by increasing equity-like characteristics or satisfying certain debt covenants), or provide capital for strategic initiatives such as acquisitions, refinancing existing debt, or funding operations without diluting existing equity holders.